This study aims to address these gaps by evaluating vitamin D levels and VDR polymorphisms and their association with clinical and biological outcomes in patients hospitalized with severe influenza and COVID-19 during the 2023–2024 winter season. The gene discussed is VDR; the disease is influenza.